ALAMAR BIOSCIENCES, INC. RETAINS LISTING ON THE NASDAQ SMALLCAP MARKET - Nasdaq SmallCap Market.SACRAMENTO, Calif.--(BUSINESS WIRE)--June 5, 1995--ALAMAR BIOSCIENCES, INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic. Antonym: dec. . (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : ALMR ALMR Advanced Liquid Metal Reactor ALMR Association of Licensed Multiple Retailers (UK) ALMR Alaska Land Mobile Radio ALMR Association of Lighting & Mercury Recyclers (USA) ALMR A Last Minute Resource , ALMRW), today announced that the Company's stock has met the conditions for the continued inclusion of its securities on the Nasdaq SmallCap Market. Effective immediately, the Company's securities will be traded under the symbols ALMR and ALMRW, respectively. In April, Alamar had announced that Nasdaq had granted it a temporary exception to its capital and surplus requirement which the Company had failed to meet as of December 31, 1994. However, on May 10, 1995, the Company announced that it had raised net proceeds Net Proceeds The amount received after all costs are deducted from the sale of a piece of property or security. Notes: In the case of an investor selling a security, net proceeds represent the proceeds from the sale minus any trading costs (i.e. commissions). of $1.34 million through a private stock offering which allowed for continued listing on the Nasdaq SmallCap Market. Mr. Peter Gombrich, acting Chief Executive Officer of Alamar stated, "We are very pleased to continue to be listed on the Nasdaq SmallCap Market. This listing provides Alamar with visibility in the investment community and the prospect of a broader shareholder base. We look forward to the continued accomplishment of our corporate goals as a Nasdaq listed company listed company n → compañía cotizable listed company n → société cotée en Bourse listed company list n → ." Alamar Biosciences, Inc. manufactures and markets manual and semi-automated bacterial susceptibility and identification testing products, using Alamar's proprietary alamarBlue redox redox (rē`dŏks): see oxidation and reduction. technology, to hospitals and reference laboratories primarily in the U.S. and Europe. On April 24, 1995 Alamar announced a definitive agreement to merge with privately held AccuMed, Inc., a provider of laboratory diagnostic products headquartered in Chicago with facilities in Cleveland and the United Kingdom. Upon the completion of the merger the surviving entity will be called AccuMed International, Inc. CONTACT: Michele Fasano Lippert/Heilshorn & Associates (212) 838-3777 or Company Contacts: Mark Santor Chief Financial Officer Alamar Biosciences, Inc. (916) 567-3475 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion